Detalhe da pesquisa
1.
A pre-implementation examination of barriers and facilitators of an electronic prospective surveillance model for cancer rehabilitation: a qualitative study.
BMC Health Serv Res
; 24(1): 17, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178095
2.
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database.
Br J Haematol
; 193(3): 532-541, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559897
3.
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
Am J Hematol
; 96(5): 552-560, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650179
4.
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
J Nat Prod
; 83(12): 3526-3535, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210536
5.
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.
Am J Hematol
; 98(1): E15-E19, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35604280
6.
Making It Happen: Middle Managers' Roles in Innovation Implementation in Health Care.
Worldviews Evid Based Nurs
; 15(6): 414-423, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291739
7.
Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma.
Cancer
; 121(5): 716-23, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355245
8.
Effects of supervised exercise on progression-free survival in lymphoma patients: an exploratory follow-up of the HELP Trial.
Cancer Causes Control
; 26(2): 269-276, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25491935
9.
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial.
Blood
; 121(9): 1517-23, 2013 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297129
10.
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.
Blood
; 128(5): 732-5, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338095
11.
Patient satisfaction with participation in a randomized exercise trial: effects of randomization and a usual care posttrial exercise program.
Clin Trials
; 10(6): 959-66, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23918843
12.
MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target.
Exp Hematol
; 123: 34-45, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137439
13.
TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma.
Cancer Rep (Hoboken)
; 6(10): e1879, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539777
14.
Implementation of electronic prospective surveillance models in cancer care: a scoping review.
Implement Sci
; 18(1): 11, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101231
15.
In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival.
Mol Cancer
; 11: 78, 2012 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23083101
16.
Predictors of follow-up exercise behavior 6 months after a randomized trial of supervised exercise training in lymphoma patients.
Psychooncology
; 21(10): 1124-31, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21766483
17.
Dietary patterns of patients with advanced lung or colorectal cancer.
Can J Diet Pract Res
; 73(4): e298-303, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23217447
18.
Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.
Cancer
; 117(16): 3774-80, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21328326
19.
Nanoparticle surface-enhanced Raman spectroscopy as a noninvasive, label-free tool to monitor hematological malignancy.
Nanomedicine (Lond)
; 16(24): 2175-2188, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547916
20.
A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.
Blood
; 112(7): 2935-45, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18535198